Letter to the Editor
Expanding indications of omalizumab therapy in the absence of specific IgE
Read
2587
Timeswas read the article
778
Total PDF
1809
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 12 | 10 | 22 |
| 2024 March | 11 | 9 | 20 |
| 2024 February | 20 | 2 | 22 |
| 2024 January | 24 | 15 | 39 |
| 2023 December | 15 | 8 | 23 |
| 2023 November | 14 | 9 | 23 |
| 2023 October | 35 | 8 | 43 |
| 2023 September | 19 | 15 | 34 |
| 2023 August | 10 | 9 | 19 |
| 2023 July | 13 | 7 | 20 |
| 2023 June | 11 | 3 | 14 |
| 2023 May | 5 | 4 | 9 |
| 2023 April | 3 | 4 | 7 |
| 2023 March | 7 | 2 | 9 |
| 2023 February | 6 | 6 | 12 |
| 2023 January | 8 | 5 | 13 |
| 2022 December | 8 | 10 | 18 |
| 2022 November | 13 | 4 | 17 |
| 2022 October | 11 | 10 | 21 |
| 2022 September | 9 | 7 | 16 |
| 2022 August | 14 | 4 | 18 |
| 2022 July | 10 | 7 | 17 |
| 2022 June | 8 | 5 | 13 |
| 2022 May | 8 | 6 | 14 |
| 2022 April | 13 | 6 | 19 |
| 2022 March | 11 | 12 | 23 |
| 2022 February | 5 | 3 | 8 |
| 2022 January | 11 | 4 | 15 |
| 2021 December | 8 | 13 | 21 |
| 2021 November | 8 | 6 | 14 |
| 2021 October | 10 | 11 | 21 |
| 2021 September | 9 | 20 | 29 |
| 2021 August | 4 | 8 | 12 |
| 2021 July | 13 | 13 | 26 |
| 2021 June | 7 | 8 | 15 |
| 2021 May | 11 | 9 | 20 |
| 2021 April | 12 | 14 | 26 |
| 2021 March | 9 | 13 | 22 |
| 2021 February | 6 | 4 | 10 |
| 2021 January | 5 | 3 | 8 |
| 2020 December | 1 | 1 | 2 |
| 2020 November | 0 | 1 | 1 |
| 2020 August | 0 | 5 | 5 |
| 2020 July | 0 | 2 | 2 |
| 2020 May | 0 | 1 | 1 |
| 2020 April | 0 | 2 | 2 |
| 2020 March | 0 | 3 | 3 |
| 2020 February | 0 | 5 | 5 |
| 2019 December | 0 | 2 | 2 |
| 2019 September | 0 | 2 | 2 |
| 2019 August | 0 | 4 | 4 |
| 2019 July | 0 | 9 | 9 |
| 2019 June | 0 | 7 | 7 |
| 2019 May | 0 | 7 | 7 |
| 2019 April | 0 | 5 | 5 |
| 2019 March | 0 | 3 | 3 |
| 2019 February | 0 | 3 | 3 |
| 2019 January | 0 | 1 | 1 |
| 2018 December | 0 | 2 | 2 |
| 2018 November | 0 | 6 | 6 |
| 2018 August | 0 | 1 | 1 |
| 2018 July | 0 | 3 | 3 |
| 2018 June | 0 | 2 | 2 |
| 2018 February | 6 | 0 | 6 |
| 2018 January | 6 | 0 | 6 |
| 2017 December | 8 | 0 | 8 |
| 2017 November | 10 | 3 | 13 |
| 2017 October | 12 | 2 | 14 |
| 2017 September | 16 | 0 | 16 |
| 2017 August | 7 | 0 | 7 |
| 2017 July | 4 | 2 | 6 |
| 2017 June | 12 | 15 | 27 |
| 2017 May | 25 | 0 | 25 |
| 2017 April | 10 | 3 | 13 |
| 2017 March | 6 | 86 | 92 |
| 2017 February | 10 | 7 | 17 |
| 2017 January | 2 | 0 | 2 |
| 2016 December | 14 | 6 | 20 |
| 2016 November | 13 | 3 | 16 |
| 2016 October | 17 | 13 | 30 |
| 2016 September | 8 | 1 | 9 |
| 2016 August | 12 | 2 | 14 |
| 2016 July | 4 | 1 | 5 |
| 2016 June | 10 | 7 | 17 |
| 2016 May | 17 | 11 | 28 |
| 2016 April | 7 | 7 | 14 |
| 2016 March | 5 | 10 | 15 |
| 2016 February | 10 | 13 | 23 |
| 2016 January | 9 | 8 | 17 |
| 2015 December | 9 | 6 | 15 |
| 2015 November | 8 | 4 | 12 |
| 2015 October | 13 | 8 | 21 |
| 2015 September | 7 | 4 | 11 |
| 2015 August | 8 | 3 | 11 |
| 2015 July | 3 | 3 | 6 |
| 2015 June | 3 | 2 | 5 |
| 2015 May | 4 | 2 | 6 |
| 2015 April | 8 | 10 | 18 |
| 2015 March | 5 | 6 | 11 |
| 2015 February | 7 | 1 | 8 |
| 2015 January | 15 | 0 | 15 |
| 2014 December | 22 | 5 | 27 |
| 2014 November | 13 | 2 | 15 |
| 2014 October | 22 | 7 | 29 |
| 2014 September | 18 | 5 | 23 |
| 2014 August | 10 | 1 | 11 |
| 2014 July | 7 | 5 | 12 |
| 2014 June | 5 | 0 | 5 |
| 2014 May | 3 | 0 | 3 |
| 2014 April | 3 | 1 | 4 |
| 2014 March | 30 | 5 | 35 |
| 2014 February | 26 | 8 | 34 |
| 2014 January | 18 | 7 | 25 |
| 2013 December | 28 | 9 | 37 |
| 2013 November | 18 | 14 | 32 |
| 2013 October | 20 | 5 | 25 |
| 2013 September | 22 | 8 | 30 |
| 2013 August | 27 | 7 | 34 |
| 2013 July | 32 | 13 | 45 |
| 2013 June | 11 | 1 | 12 |
| 2013 May | 19 | 6 | 25 |
| 2013 April | 19 | 7 | 26 |
| 2013 March | 15 | 4 | 19 |
| 2013 February | 5 | 5 | 10 |
| 2013 January | 2 | 2 | 4 |
| 2012 December | 4 | 2 | 6 |
| 2012 November | 0 | 5 | 5 |
| 2012 October | 2 | 2 | 4 |
| 2011 April | 621 | 0 | 621 |
Show all
